An Integrative Roadmap for Advancing Colorectal Cancer Organoid

Area of Science:

• Oncology
• Translational Medicine
• Biotechnology

Background:

• Colorectal cancer (CRC) is a major global health concern.
• Patient-derived CRC organoids better mimic primary tumors than 2D models.
• Organoid systems are evolving towards complex co-culture and mini-colon models.

Purpose of the Study:

• To review advancements in CRC organoid technology.
• To identify limitations and future directions for CRC organoid research.
• To propose a roadmap for next-generation CRC organoid platforms and computational frameworks.

Main Methods:

• Utilizing patient-derived colorectal cancer (CRC) organoids.
• Incorporating immune-organoid co-culture and mini-colon systems.
• Leveraging high-throughput technologies, CRISPR-based functional genomics, and multi-omics.

Main Results:

• Advanced organoid platforms enhance the study of CRC mechanisms and drug responses.
• Current models lack systemic physiology and standardization, requiring further development.
• Next-generation platforms and AI-driven approaches promise accelerated discovery and personalized therapy.

Conclusions:

• CRC organoid research is advancing rapidly, bridging basic science and clinical application.
• Future directions include developing standardized, complex organoid systems and integrating computational tools.
• These advancements are crucial for accelerating CRC research, enabling personalized medicine, and improving clinical outcomes.